Esperion Therapeutics (0ET.F) Q3 2024 Earnings

12AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.46
-0.2
0.06
0.32

Details

Expected EPS
-0.15741100206
Actual EPS
-0.30175860000000004
Surprise EPS
-0.14
Surprise Percent
+91.7%

Description

Esperion Therapeutics (0ET.F) has reported earnings of -0.30175860000000004 per share for Q3 2024.

0 Comments

Share your thoughts